Heart, Lung and Circulation
Brief Communication| Volume 24, ISSUE 6, P614-616, June 2015

The Scientific Foundation, Rationale and Argument for a Nonfrequentist Bayesian Analysis in Clinical Trials in Coronary Artery Disease

Published:December 11, 2014DOI:
      Randomised control trials (RCT) are considered the gold standard for the strength of evidence used in formulation of guidelines in the contemporary clinical practice. The analysis is based on the design of an experiment that analyses data collected in a future event space with no regard to past observations. It bases its conclusions on arbitrary values of significance that might not be clinically relevant or plausible. A Bayesian analysis looks at all the past evidence and observations to reach a conclusion and does not have the shortcomings of a RCT.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Stigler S.M.
        The History of Statistics: The Measurement of Uncertainty before 1900.
        Harvard University Press, Cambridge, MA1990
        • Bayes Thomas
        • Price Mr
        An Essay towards solving a Problem in the Doctrine of Chances.
        Philosophical Transactions of the Royal Society of London. 1763; 53: 370-418
        • Spiegelhalter D.J.
        • Myles J.P.
        • Jones D.R.
        • Abrams K.R.
        Bayesian methods in health technology assessment: a review.
        Health Technol Assess. 2000; 4: 1-130
        • Kadane J.
        • Wolfson L.
        Priors for the design and analysis of clinical trials.
        in: Berry D.A. Stangl D.K. Bayesian biostatistics. Marcel Dekker, New York1996: 157-184
        • Lytle B.W.
        • Blackstone E.H.
        • Loop F.D.
        • Houghtaling P.L.
        • Arnold J.H.
        • Akhrass R.
        • et al.
        Two internal thoracic artery grafts are better than one.
        J Thorac Cardiovasc Surg. 1999; 117: 855-872
        • Weiss A.J.
        • Zhao S.
        • Tian D.H.
        • Taggart D.P.
        • Yan T.D.
        A meta-analysis comparing bilateral internal mammary artery with left internal mammary artery for coronary artery bypass grafting.
        Ann Cardiothorac Surg. 2013; 2: 390-400
        • Tatoulis J.
        • Buxton B.F.
        • Fuller J.A.
        The right internal thoracic artery: the forgotten conduit--5,766 patients and 991 angiograms.
        Ann Thorac Surg. 2011; 92: 9-15